OS Therapies Incorporated
OSTX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $89,323 | $50,325 | $57,983 | $57,983 |
| - Cash | $5,534 | $39 | $171 | $81 |
| + Debt | $6,050 | $14,610 | $10,348 | $7,072 |
| Enterprise Value | $89,840 | $64,896 | $68,159 | $64,975 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$3 | -$4 | -$1 | -$1,160 |
| % Margin | – | – | – | – |
| EBITDA | -$6,828 | -$4,338 | -$4,445 | -$4,837 |
| % Margin | – | – | – | – |
| Net Income | -$8,883 | -$7,792 | -$6,255 | -$7,420 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.52 | -0.39 | -0.28 | -0.33 |
| % Growth | -33.3% | -39.3% | 15.2% | – |
| Operating Cash Flow | -$7,282 | -$3,007 | -$3,793 | -$4,403 |
| Capital Expenditures | $0 | $0 | $0 | -$12 |
| Free Cash Flow | -$7,282 | -$3,007 | -$3,793 | -$4,415 |